This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Mark P. Jarrett, MD; Subramanyan Santhanam, MD; Francesco Del Greco, MD

Arch Intern Med. 1983;143(7):1353-1356.

Abstract
• Despite treatment advances, renal failure still develops in patients with systemic lupus erythematosus (SLE). With the common use of long-term maintenance hemodialysis, this complication is no longer fatal. In order to evaluate factors that contribute to the outcome of patients with SLE receiving long-term hemodialysis, we retrospectively analyzed the clinical course of 14 patients with SLE receiving hemodialysis for more than three months, and compared them with 62 patients receiving long-term hemodialysis who did not have SLE. While receiving long-term hemodialysis, SLE activity was minimal, with most manifestations involving the CNS or synovitis. Five-year survival was significantly lower in the SLE than in the non-SLE group (58.6% v 88.5%), but no deaths were directly attributable to SLE activity. Morbidity in the SLE group was primarily due to infection and vascular access problems.

(Arch Intern Med 1983;143:1353-1356)

Author Affiliations
From the Department of Medicine, Sections of Arthritis and Connective Tissue Disease (Dr Jarrett) and Nephrology (Drs Santhanam and Del Greco), Northwestern University Medical School, Chicago. Dr Jarrett is currently with the Department of Medicine, Division of Rheumatology, State University of New York Downstate Medical Center.

Footnotes
Accepted for publication March 1, 1983.

Reprint requests to Northwestern University Medical School, 303 E Chicago Ave, Chicago, IL 60611 (Dr Santhanam).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics
Bertsias et al.
Ann Rheum Dis 2008;67:195-205.
ABSTRACT | FULL TEXT  

Poor prognosis of end-stage renal disease in systemic lupus erythematosus: a cohort of Chinese patients
Lee et al.
Lupus 2003;12:827-832.
ABSTRACT  

Unusual lung consolidation in SLE
Nomura et al.
Thorax 2003;58:367-367.
FULL TEXT  

Systemic Lupus Erythematosus after Renal Transplantation: Patient and Graft Survival and Disease Activity
Nossent et al.
ANN INTERN MED 1991;114:183-188.
ABSTRACT